Decreased COPD prevalence in Sweden after decades of decrease in smoking

Abstract Background COPD has increased in prevalence worldwide over several decades until the first decade after the millennium shift. Evidence from a few recent population studies indicate that the prevalence may be levelling or even decreasing in some areas in Europe. Since the 1970s, a substantia...

Full description

Bibliographic Details
Main Authors: Backman, Helena, Vanfleteren, Lowie, Lindberg, Anne, Ekerljung, Linda, Stridsman, Caroline, Axelsson, Malin, Nilsson, Ulf, Bright I. Nwaru, Sawalha, Sami, Berne Eriksson, Hedman, Linnea, Rådinger, Madeleine, Sven-Arne Jansson, Ullman, Anders, Kankaanranta, Hannu, Lötvall, Jan, Rönmark, Eva, Lundbäck, Bo
Format: Article in Journal/Newspaper
Language:unknown
Published: figshare 2020
Subjects:
Online Access:https://dx.doi.org/10.6084/m9.figshare.c.5190993
https://springernature.figshare.com/collections/Decreased_COPD_prevalence_in_Sweden_after_decades_of_decrease_in_smoking/5190993
Description
Summary:Abstract Background COPD has increased in prevalence worldwide over several decades until the first decade after the millennium shift. Evidence from a few recent population studies indicate that the prevalence may be levelling or even decreasing in some areas in Europe. Since the 1970s, a substantial and ongoing decrease in smoking prevalence has been observed in several European countries including Sweden. The aim of the current study was to estimate the prevalence, characteristics and risk factors for COPD in the Swedish general population. A further aim was to estimate the prevalence trend of COPD in Northern Sweden from 1994 to 2009. Methods Two large random population samples were invited to spirometry with bronchodilator testing and structured interviews in 2009–2012, one in south-western and one in northern Sweden, n = 1839 participants in total. The results from northern Sweden were compared to a study performed 15 years earlier in the same area and age-span. The diagnosis of COPD required both chronic airway obstruction (CAO) and the presence of respiratory symptoms, in line with the GOLD documents since 2017. CAO was defined as post-bronchodilator FEV1/FVC